A Study of LY4515100 in Healthy Participants

NCT07339722 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY4515100 via SAD
DRUG: LY4515100 via MAD

Sponsor

Eli Lilly and Company